Association Between Chemotherapy-Related Cognitive Impairment and Biomarkers in Older Patients With Cancer: A Systematic Review

Read full text Summarise with VIRAT
Authors: Ji Young Lee, Soomin Hong
Cited by: 0
References: 56

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

PURPOSE: Chemotherapy-related cognitive impairment (CRCI) is a prevalent and distressing issue among older adults with cancer, affecting quality of life and treatment adherence. While its mechanisms remain unclear, biomarkers have emerged as promising tools for understanding CRCI. This systematic review aimed to explore the relationships between cognitive impairment following chemotherapy and biomarkers in older patients with cancer. METHODS: A comprehensive search was conducted through December 2024 across PubMed, CINAHL, Embase, PsycINFO, and the Cochrane Library. An additional hand search was performed through July 2025. The focus was on patients over 60 years of age with CRCI and associated biomarkers. The review adhered to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses 2020 guidelines, and the methodological quality of included studies was assessed using the Joanna Briggs Institute checklist to ensure rigor and reliability. RESULTS: Six of the initial 6324 articles met the inclusion criteria, and seven additional studies were identified through manual searching. In total, 13 studies identified several biomarkers associated with CRCI in older patients with cancer. These included serum hemoglobin, brain-derived neurotrophic factor, percent cerebral oxyhemoglobin, functional network connectivity, and individual alpha peak frequency. CONCLUSIONS: This review highlights several biomarkers potentially associated with CRCI in older patients with cancer, though consistent and definitive biomarkers remain elusive. Further research is needed to clarify the biological mechanisms underlying CRCI and inform the development of interventions aimed at preventing cognitive decline in this vulnerable population. The identification of validated biomarkers will be critical for advancing personalized nursing and improving clinical outcomes in older adults with cancer. The research protocol was registered in advance on the International Prospective Register of Systematic Reviews under CRD42022353113.

Fields of Study & Subjects

Cancer-related cognitive impairment studies Intensive Care Unit Cognitive Disorders Frailty in Older Adults

Publication details

Journal / source
Asian Nursing Research
Volume
20
Issue
2
Pages
197–208
Publication date
31 March 2026
Language
EN